肌萎缩侧索硬化患者上运动神经元密度的MR成像估算:可行性研究
该可行性研究对11例ALS患者死后行离体脑MR成像并量化右侧初级运动皮层运动神经元密度,发现密度在终末期ALS患者间差异超过三倍,可由标准化灰质体积线性估算(校正R²=0.51,P=0.008),散发性ALS中联合标准化RPMC与白质体积估算更准(校正R²=0.98,P=0.01)。
要点
- 终末期ALS患者初级运动皮层运动神经元密度差异可超过三倍。
- 标准化灰质体积可线性估算运动神经元密度(校正R²=0.51,P=0.008)。
- 散发性ALS中联合标准化RPMC与白质体积估算更准(校正R²=0.98,P=0.01)。
核心结论
- 初级运动皮层平均运动神经元密度在终末期ALS中差异很大,可能源于疾病异质性;MR成像指标有潜力用于估算运动神经元密度。
研究设计与样本
- 可行性研究,2012至2014年纳入11例ALS患者(年龄35-81岁,女7例、男4例),死后平均5.5小时(范围3.2-9.6小时)行原位脑MR成像,切除右侧初级运动皮层并量化运动神经元密度;另用相同成像方案在6例在体ALS患者(年龄54-66岁,女3例、男3例)中测试模型。
诊断标准与关键数值
- 以标准化灰质体积线性函数估算运动神经元密度:校正R²=0.51,P=0.008,多数患者误差<10%。
- 仅考虑散发性ALS时,以标准化RPMC与白质体积线性函数估算运动神经元密度:校正R²=0.98,P=0.01,全部患者误差<10%。
局限性
- 本研究为可行性研究,样本量小(离体11例、在体6例)。
- 结论用possibly、can potentially等限定语气,提示需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine if magnetic resonance (MR) imaging metrics can estimate primary motor cortex (PMC) motor neuron (MN) density in patients with amyotrophic lateral sclerosis (ALS). Materials and Methods Between 2012 and 2014, in situ brain MR imaging was performed in 11 patients with ALS (age range, 35-81 years; seven women and four men) soon after death (mean, 5.5 hours after death; range, 3.2-9.6 hours). The brain was removed, right PMC (RPMC) was excised, and MN density was quantified. RPMC metrics (thickness, volume, and magnetization transfer ratio) were calculated from MR images. Regression modeling was used to estimate MN density by using RPMC and global MR imaging metrics (brain and tissue volumes); clinical variables were subsequently evaluated as additional estimators. Models were tested at in vivo MR imaging by using the same imaging protocol (six patients with ALS; age range, 54-66 years; three women and three men). Results RPMC mean MN density varied over a greater than threefold range across patients and was estimated by a linear function of normalized gray matter volume (adjusted R2 = 0.51; P = .008; <10% error in most patients). When considering only sporadic ALS, a linear function of normalized RPMC and white matter volumes estimated MN density (adjusted R2 = 0.98; P = .01; <10% error in all patients). In vivo data analyses detected decreases in MN density over time. Conclusion PMC mean MN density varies widely in end-stage ALS possibly because of disease heterogeneity. MN density can potentially be estimated by MR imaging metrics. © RSNA, 2018 Online supplemental material is available for this article.
引用
- Chen J, Kostenko V, Pioro EP, et al. MR Imaging-based Estimation of Upper Motor Neuron Density in Patients with Amyotrophic Lateral Sclerosis: A Feasibility Study. Radiology. 2018. PMID: 29361242. doi:10.1148/radiol.2018162967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。